About Accolade
Accolade is a company based in Plymouth Meeting (United States) founded in 2007 was acquired by Transcarent in January 2025. Accolade has raised $228.3 million across 11 funding rounds from investors including McKesson, Transcarent and Andreessen Horowitz. Accolade has completed 3 acquisitions, including 2nd MD, MD Insider and Plushcare. Accolade offers products and services including Accolade Care, Accolade Plus, Accolade Connect, 2nd.MD by Accolade, and Enhanced Rx. Accolade operates in a competitive market with competitors including Hinge Health, Practo, Sharecare, Spendesk and Betterfly, among others.
- Headquarter Plymouth Meeting, United States
- Stage Public
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Accolade Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$228.3 M (USD)
in 11 rounds
-
Latest Funding Round
$11.25 M (USD), Post-IPO
Oct 15, 2021
-
Investors
McKesson
& 8 more
-
Employee Count
Not available
-
Investments & Acquisitions
2nd MD
& 2 more
-
Acquired by
Transcarent
(Jan 08, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accolade
Accolade offers a comprehensive portfolio of products and services, including Accolade Care, Accolade Plus, Accolade Connect, 2nd.MD by Accolade, and Enhanced Rx.
Platform for personalized care navigation and support services.
Enhances care delivery with advanced health management tools.
Facilitates virtual consultations and health coordination.
Provides second opinions on medical diagnoses and treatments.
Manages prescriptions for better health outcomes and cost savings.
People of Accolade
Unlock access to complete
Unlock access to complete
Software Development Team
61 people
Leadership Team
57 people
Product Management Team
23 people
Operations Team
18 people
Sales and Marketing
13 people
Senior Team
11 people
Data Analysis and Operations Team
10 people
Sr. Team
9 people
Unlock access to complete
Funding Insights of Accolade
Accolade has successfully raised a total of $228.3M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $11.25 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Accolade
Accolade has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include McKesson, Transcarent and Andreessen Horowitz.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology sectors are handled by Andreessen Horowitz.
|
Locked | Locked | Locked | |
|
PE firm invests in the US
|
Locked | Locked | Locked | |
|
Venture capital investing in AI, biotech, and technology sectors, focusing on seed and early stages in Seattle and beyond.
|
Locked | Locked | Locked |
Investor details for Accolade
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accolade
Accolade has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include 2nd MD, MD Insider and Plushcare.
Investment portfolio details for Accolade
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Primary healthcare is delivered through telemedicine services.
|
Locked | Locked | 2014 | Locked | |
|
Physician quality scores are derived from mined health data.
|
Locked | Locked | 2012 | Locked | |
|
Second medical opinions are delivered to employees via teleconsultation platform.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Accolade
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Accolade
Detailed financials for Accolade
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accolade Comparisons
Peer comparison for Accolade
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accolade
Accolade operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hinge Health, Practo, Sharecare, Spendesk and Betterfly, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Virtual physical therapy and digital pain care solutions are provided.
|
|
| Locked | Locked | Locked |
Doctor appointments are booked and healthcare professionals are consulted online.
|
|
| Locked | Locked | Locked |
Health and wellness social network for employees is provided.
|
|
| Locked | Locked | Locked |
Provider of prepaid cards for financial benefits of employees
|
|
| Locked | Locked | Locked |
Employee health and well-being solutions are delivered through a platform.
|
Detailed competitors of Accolade
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accolade
Complete news archive for Accolade
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accolade
Accolade was founded in 2007.
Accolade is headquartered in Plymouth Meeting, United States. It is registered at Plymouth Meeting, Pennsylvania, United States.
Accolade is a funded company, having raised a total of $228.3M across 11 funding rounds to date.
Accolade was founded in 2007 and is headquartered in Plymouth Meeting, United States. Operations focus on the healthcare sector, where a cloud-based platform is provided to support employee benefits for employers and payers. Services include consumer engagement tools, a web portal, and an app-based health assistant for accessing clinical guidance, population health management, and benefits comparisons. Healthcare needs are addressed through these integrated solutions.
Accolade's top competitors include Hinge Health, Wellhub and Sharecare.
Accolade offers Accolade Care, Accolade Plus, Accolade Connect, 2nd.MD by Accolade, and Enhanced Rx.
Accolade has made 3 acquisitions, including 2nd MD, MD Insider, and Plushcare.
Accolade has 9 investors. Key investors include McKesson, Transcarent, Andreessen Horowitz, Carrick Capital Partners, and Madrona.